Clinical Trial Update: Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial [Phase 2]

View source ↗

Summary

The document notes that the Phase 2 randomized trial of naltrexone/acetaminophen for acute migraine treatment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Acetaminophen (Acetaminophen)
• Naltrexone (Naltrexone)

Snippet

Sponsor: Allodynic Therapeutics, Inc | Conditions: Migraine | Phase 2 | Status: WITHDRAWN